Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: Results from the Dutch population-based PHAROS MDS registry

Dinmohamed, A. G., Van Norden, Y., Visser, O., Posthuma, E. F. M., Huijgens, P. C., Sonneveld, P., … Jongen-Lavrencic, M. (2015, December 1). Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: Results from the Dutch population-based PHAROS MDS registry. Leukemia. Nature Publishing Group. https://doi.org/10.1038/leu.2015.220